Analyst Ratings For NASDAQ:BKYI – Bio-Key International (NASDAQ:BKYI)
Today, Maxim Group initiated coverage on NASDAQ:BKYI – Bio-Key International (NASDAQ:BKYI) with a Buy with a price target of $5.50.
Some recent analyst ratings include
- 4/24/2018-Maxim Group initiated coverage with a Buy rating.
Recent Insider Trading Activity For NASDAQ:BKYI – Bio-Key International (NASDAQ:BKYI)
NASDAQ:BKYI – Bio-Key International (NASDAQ:BKYI) has insider ownership of 11.40% and institutional ownership of 1.58%.
- On 4/3/2018 Fong Wong Kwok, Insider, bought 91,820 with an average share price of $3.60 per share and the total transaction amounting to $330,552.00.
- On 9/22/2017 Fong Wong Kwok, Insider, bought 427,778 with an average share price of $3.60 per share and the total transaction amounting to $1,540,000.80.
- On 8/31/2017 Fong Wong Kwok, Insider, bought 26,300 with an average share price of $3.10 per share and the total transaction amounting to $81,530.00.
- On 4/28/2017 Fong Wong Kwok, Insider, bought 277,778 with an average share price of $3.60 per share and the total transaction amounting to $1,000,000.80.
- On 11/18/2016 Fong Wong Kwok, Director, bought 6,200,000 with an average share price of $0.30 per share and the total transaction amounting to $1,860,000.00.
- On 9/16/2016 Fong Wong Kwok, Director, bought 651,500 with an average share price of $0.25 per share and the total transaction amounting to $162,875.00.
- On 9/15/2016 Fong Wong Kwok, Director, bought 925,200 with an average share price of $0.25 per share and the total transaction amounting to $231,300.00.
Recent Trading Activity for NASDAQ:BKYI – Bio-Key International (NASDAQ:BKYI)
Shares of NASDAQ:BKYI – Bio-Key International closed the previous trading session at 2.14 up +0.05 2.35% with 16051 shares trading hands.